The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis

Background: Nonalcoholic fatty liver disease is considered to be the hepatic component of metabolic syndrome (MetS). However, the association between changes in MetS status and the risk of liver cirrhosis (LC) has not been investigated to date. This study assessed the association between changes in...

Full description

Bibliographic Details
Main Authors: Goh-Eun Chung, Young Chang, Yuri Cho, Eun-Ju Cho, Jeong-Ju Yoo, Sang-Hyun Park, Kyungdo Han, Dong-Wook Shin, Su-Jong Yu, Yoon-Jun Kim, Jung-Hwan Yoon
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/12/1948
_version_ 1797506462328553472
author Goh-Eun Chung
Young Chang
Yuri Cho
Eun-Ju Cho
Jeong-Ju Yoo
Sang-Hyun Park
Kyungdo Han
Dong-Wook Shin
Su-Jong Yu
Yoon-Jun Kim
Jung-Hwan Yoon
author_facet Goh-Eun Chung
Young Chang
Yuri Cho
Eun-Ju Cho
Jeong-Ju Yoo
Sang-Hyun Park
Kyungdo Han
Dong-Wook Shin
Su-Jong Yu
Yoon-Jun Kim
Jung-Hwan Yoon
author_sort Goh-Eun Chung
collection DOAJ
description Background: Nonalcoholic fatty liver disease is considered to be the hepatic component of metabolic syndrome (MetS). However, the association between changes in MetS status and the risk of liver cirrhosis (LC) has not been investigated to date. This study assessed the association between changes in MetS and subsequent nonviral LC development. Methods: Data were obtained from the Korean National Health Insurance Service. Individuals who participated in health screenings from both 2009 to 2010 and 2011 to 2012 were included. The primary outcome was LC development according to the static and dynamic MetS status. Subjects were stratified into four groups according to the change in MetS status observed from the two-year interval screening (2009–2011). Cox regression analysis was used to examine the hazard ratios of LC. Results: During a median of 7.3 years of follow-up, 24,923 incident LC cases developed among 5,975,308 individuals. After adjusting for age, sex, smoking, alcohol, regular exercise, and body mass index, the adjusted hazard ratios (95% confidence intervals) for LC development were 1.39 (1.33–1.44) for the MetS-Developed group, 1.32 (1.26–1.37) for the MetS-Recovered group, and 1.51 (1.45–1.56) for the MetS-Sustained group, relative to the MetS-Free group. Stratified analyses according to age, sex, smoking, alcohol intake, exercise, diabetes mellitus, hypertension, dyslipidemia, and chronic kidney disease showed similar results. Conclusions: Both static and dynamic MetS status are independent risk factors for LC development. The risk of LC was the highest in people with sustained MetS and was lower in the MetS-Recovered group than in the MetS-Sustained group. These results suggest that improving a person’s MetS status may be helpful in preventing LC.
first_indexed 2024-03-10T04:33:56Z
format Article
id doaj.art-a772d36e028c49ee9968744d9fcc690c
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T04:33:56Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-a772d36e028c49ee9968744d9fcc690c2023-11-23T03:58:03ZengMDPI AGBiomedicines2227-90592021-12-01912194810.3390/biomedicines9121948The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver CirrhosisGoh-Eun Chung0Young Chang1Yuri Cho2Eun-Ju Cho3Jeong-Ju Yoo4Sang-Hyun Park5Kyungdo Han6Dong-Wook Shin7Su-Jong Yu8Yoon-Jun Kim9Jung-Hwan Yoon10Department of Internal Medicine, Healthcare Research Institute, Gangnam Healthcare Center, Seoul National University Hospital, Seoul 06236, KoreaDepartment of Internal Medicine, Digestive Disease Center, Institute for Digestive Research, Soonchunhyang University College of Medicine, Seoul 04401, KoreaCenter for Liver and Pancreatobiliary Cancer, Research Institute and Hospital, National Cancer Center, Goyang 10408, KoreaDepartment of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul 03080, KoreaDepartment of Gastroenterology and Hepatology, Soonchunhyang University Bucheon Hospital, Bucheon 14584, KoreaDepartment of Biostatistics, College of Medicine, The Soongsil University, Seoul 06591, KoreaDepartment of Biostatistics, College of Medicine, The Soongsil University, Seoul 06591, KoreaSamsung Medical Center, Department of Family Medicine, Sungkyunkwan University School of Medicine, Seoul 06351, KoreaDepartment of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul 03080, KoreaDepartment of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul 03080, KoreaDepartment of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul 03080, KoreaBackground: Nonalcoholic fatty liver disease is considered to be the hepatic component of metabolic syndrome (MetS). However, the association between changes in MetS status and the risk of liver cirrhosis (LC) has not been investigated to date. This study assessed the association between changes in MetS and subsequent nonviral LC development. Methods: Data were obtained from the Korean National Health Insurance Service. Individuals who participated in health screenings from both 2009 to 2010 and 2011 to 2012 were included. The primary outcome was LC development according to the static and dynamic MetS status. Subjects were stratified into four groups according to the change in MetS status observed from the two-year interval screening (2009–2011). Cox regression analysis was used to examine the hazard ratios of LC. Results: During a median of 7.3 years of follow-up, 24,923 incident LC cases developed among 5,975,308 individuals. After adjusting for age, sex, smoking, alcohol, regular exercise, and body mass index, the adjusted hazard ratios (95% confidence intervals) for LC development were 1.39 (1.33–1.44) for the MetS-Developed group, 1.32 (1.26–1.37) for the MetS-Recovered group, and 1.51 (1.45–1.56) for the MetS-Sustained group, relative to the MetS-Free group. Stratified analyses according to age, sex, smoking, alcohol intake, exercise, diabetes mellitus, hypertension, dyslipidemia, and chronic kidney disease showed similar results. Conclusions: Both static and dynamic MetS status are independent risk factors for LC development. The risk of LC was the highest in people with sustained MetS and was lower in the MetS-Recovered group than in the MetS-Sustained group. These results suggest that improving a person’s MetS status may be helpful in preventing LC.https://www.mdpi.com/2227-9059/9/12/1948metabolic syndromecirrhosisincidencenationwide
spellingShingle Goh-Eun Chung
Young Chang
Yuri Cho
Eun-Ju Cho
Jeong-Ju Yoo
Sang-Hyun Park
Kyungdo Han
Dong-Wook Shin
Su-Jong Yu
Yoon-Jun Kim
Jung-Hwan Yoon
The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis
Biomedicines
metabolic syndrome
cirrhosis
incidence
nationwide
title The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis
title_full The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis
title_fullStr The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis
title_full_unstemmed The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis
title_short The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis
title_sort change in metabolic syndrome status and the risk of nonviral liver cirrhosis
topic metabolic syndrome
cirrhosis
incidence
nationwide
url https://www.mdpi.com/2227-9059/9/12/1948
work_keys_str_mv AT goheunchung thechangeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT youngchang thechangeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT yuricho thechangeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT eunjucho thechangeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT jeongjuyoo thechangeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT sanghyunpark thechangeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT kyungdohan thechangeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT dongwookshin thechangeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT sujongyu thechangeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT yoonjunkim thechangeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT junghwanyoon thechangeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT goheunchung changeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT youngchang changeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT yuricho changeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT eunjucho changeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT jeongjuyoo changeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT sanghyunpark changeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT kyungdohan changeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT dongwookshin changeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT sujongyu changeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT yoonjunkim changeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis
AT junghwanyoon changeinmetabolicsyndromestatusandtheriskofnonvirallivercirrhosis